Biotechnology Cancer Cures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: david james who wrote (156)	5/18/2000 12:16:00 AM
From: Mike McFarland	Read Replies (2) of 226

Although my stock play on AAV is Targeted Genetics, Cell Genesys sure looks like a no-brainer (the kind I like, heh) --so can anybody explain why the shares are dragging around down so close to book value, is this one of those situations where the stock is being held down/shinanigans? I am looking for a quick and easy answer where perhaps there is none. Folks here in Seattle can tune in to Serious Monday Friday evening to see the CEO of Tgen. kcts.org David, yes--I think we are all holding our breath hoping to see that Biotech has a decent pre-summer rally in store for it. Somewhere between Greenspan and this new crop of blowhard bears there is room for a nice rally to squeeze in here.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next